Assessment of safety of the major antimalarial drugs

Author： Chattopadhyay Rana Mahajan Babita Kumar Sanjai

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.6, Iss.5, 2007-09, pp. : 505-521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Cardiac Safety Assessment of Drugs

By Hanton Gilles

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 213-228

Adis International

Access to resources Recommend Favorite

Immunotoxicology: Role in the Safety Assessment of Drugs

By Jacques Descotes

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 127-136

Adis International

Access to resources Recommend Favorite

Emerging targets for antimalarial drugs

By Rangarajan Pundi N Padmanaban Govinarajan

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 423-441

Informa Healthcare

Access to resources Recommend Favorite

Artemisinin drugs: novel antimalarial agents

By Price R.N.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1815-1827

Informa Healthcare

Access to resources Recommend Favorite

Enantioselective Analysis of Antimalarial Drugs and their Metabolites

Current Pharmaceutical Analysis, Vol. 6, Iss. 1, 2010-02 ,pp. : 15-29

Bentham Science Publishers

Access to resources Recommend Favorite